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Abstract
Mutations in a number of genes have been linked to inherited dilated cardiomyopathy (DCM). However, such mutations
account for only a small proportion of the clinical cases emphasising the need for alternative discovery approaches to
uncovering novel pathogenic mutations in hitherto unidentified pathways. Accordingly, as part of a large-scale N-ethyl-N-
nitrosourea mutagenesis screen, we identified a mouse mutant, Python, which develops DCM. We demonstrate that the
Python phenotype is attributable to a dominant fully penetrant mutation in the dynamin-1-like (Dnm1l ) gene, which has
been shown to be critical for mitochondrial fission. The C452F mutation is in a highly conserved region of the M domain of
Dnm1l that alters protein interactions in a yeast two-hybrid system, suggesting that the mutation might alter intramolecular
interactions within the Dnm1l monomer. Heterozygous Python fibroblasts exhibit abnormal mitochondria and peroxisomes.
Homozygosity for the mutation results in the death of embryos midway though gestation. Heterozygous Python hearts
show reduced levels of mitochondria enzyme complexes and suffer from cardiac ATP depletion. The resulting energy
deficiency may contribute to cardiomyopathy. This is the first demonstration that a defect in a gene involved in
mitochondrial remodelling can result in cardiomyopathy, showing that the function of this gene is needed for the
maintenance of normal cellular function in a relatively tissue-specific manner. This disease model attests to the importance
of mitochondrial remodelling in the heart; similar defects might underlie human heart muscle disease.
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Introduction
Idiopathic dilated cardiomyopathy (DCM) is characterised by
unexplained left ventricular (LV) cavity enlargement with LV
systolic impairment [1]. DCM is an important cause of congestive
heart failure (CHF) with a prevalence of 36 cases per 100,000 in
the United States [2]. Although the molecular pathways
responsible for DCM remain largely unknown, it is estimated
that between 20–50% of DCM cases are familial in nature, the
large majority being inherited as an autosomal dominant trait [3].
Accordingly, the study of single gene disorders that remodel the
heart to cause DCM may provide a valuable opportunity to
identify critical molecules involved in disease pathways [4].
Over the past decade, DCM-causing mutations have been
identified in genes encoding sarcomeric, cytoskeletal, nuclear
envelope, intermediary filament, sarcoplasmic reticulum and
desmosomal proteins. These findings have implicated pathogenic
mechanisms whereby structural integrity, contractile force dy-
namics, and calcium regulation within the cardiomyocyte are
perturbed. Yet such mutations only account for a minority of
DCM cases [5] and many of the genes underlying DCM remain to
be elucidated. A number of gene knockouts in the mouse produce
features of DCM, but these phenotypes are usually recessive and
so do not model the human disease. One approach that has been
applied successfully to the characterisation of new disease alleles is
the use of N-ethyl-N-nitrosourea (ENU) mutagenesis [6]. Treat-
ment of mice with ENU results in a high frequency of
predominantly single point mutations in the mouse germline that
recapitulate the spectrum of mutations observed in many human
genetic diseases. Screening of offspring reveals phenotypic
variants, and the identification of the mutations underlying the
abnormal phenotype can reveal new genetic regulators and novel
pathways associated with disease pathogenesis. Such an approach
is ‘hypothesis neutral’, making no prior assumptions about the
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nature of the genes or pathways involved. Using this approach we
describe a novel mouse model of DCM in which a mutation in the
Dynamin-1-like gene (Dnm1l) leads to autosomal dominant DCM
and congestive heart failure.
Results
Python mice develop biventricular DCM
The Python mouse was identified on the basis of rapid size
increase, piloerection, and shallow rapid breathing in a visual
screen of adult G1 offspring of ENU-mutagenized BALB/
cAnNCrl males crossed with C3H/HeH females (Figure 1A).
The phenotype was inherited in an autosomal dominant fashion
with complete penetrance in both sexes. The median age of onset
of overt symptoms of CHF on a C3H/HeN genetic background
was 91 days for females and 83 days for males. A similar
phenotype with much later onset occurred on a C57BL/6J
background (median age of onset = 164 days for females, 171 days
for males; Figure 1B) suggesting that strain-specific genetic
modifiers influence disease onset.
The hearts of Python mice were grossly dilated by the time of
overt CHF (Figure 1C). The Python hearts exhibited both biatrial
and biventricular thinning and dilatation consistent with DCM
(Figure 1D). The visible increase in size of Python mice was the
result of substantial ascites and subcutaneous oedema (Figure 1E)
accompanied on occasion by pleural effusion. In the heart,
myocyte hypertrophy and interstitial fibrosis (Figure 1F) was
evident. Morphometric analysis of MSB-stained sections revealed
that collagenous tissue increased by almost 7-fold in hearts of
terminal Python mice (Figure 1G). Prominent cardiac calcification
was also evident (Figure 1H). Python mice developed CHF under
specified pathogen-free (SPF) conditions, where infectious agents
capable of causing myocarditis were absent. There was no
microscopic evidence of myocarditis, coronary artery disease or
amyloidosis, nor was there hypertrophy of pulmonary blood
vessels that would indicate pulmonary hypertension. MRI analysis
of embryonic hearts did not reveal any obvious anatomical
abnormalities (data not shown). TUNEL staining did not reveal
accelerated apoptosis in late-stage Python hearts (data not shown).
We did observe hepatic congestion at the time of overt CHF,
preceded by increases in the plasma levels of liver enzymes
aspartate aminotransferase and alanine aminotransferase (data not
shown), possibly reflecting congestive cardiac hepatopathy sec-
ondary to heart failure.
Cardiac function was analysed in male Python mice on the
C3H/HeN background aged 71–78 days, i.e. approximately 2
weeks before overt clinical signs of CHF become evident. The
results are summarised in Table 1. Heart rates in these conscious
mice did not significantly differ between Python mice and controls,
and there were no differences in any measurement of ECG
interval duration (data not shown). However, LV catheterisation
revealed that pressure generation was severely impaired in Python
mice, with LV end-systolic pressure 22 mmHg lower than in
littermate controls, and contractility 40% lower, as measured by
dP/dtmax. This reduction was not due to differences in loading
conditions since dP/dtmax remained impaired after normalisation
to instantaneous pressure. Furthermore, the Python mice had
significantly elevated end-diastolic pressure commensurate with
impaired contractile function. Under conditions of maximal
b-adrenergic stimulation with dobutamine, Python mice had a
reduced contractile reserve and a severely impaired maximum
contractility. Consistent with these findings, aortic blood pressures
were significantly reduced. Relaxation was also impaired in
Python mice with dP/dtmin 46% lower than controls, and
significant prolongation of the isovolumetric constant of relaxation
(Tau), which is less sensitive to loading conditions. These changes
occurred in the absence of LV hypertrophy or dilatation at this
time point and were confirmed at post-mortem by no differences
in LV or RV weights. Although at this stage lung weights were
normal, indicating the absence of significant pulmonary conges-
tion, later, at the time of appearance of overt CHF (approximately
2 weeks later) gross ascites and pulmonary congestion become
rapidly manifest, consistent with the precipitous deterioration in
LV function. No thrombi were observed in the atria, nor, indeed,
in any heart chamber (data not shown). Finally, haematocrits were
normal in all mice (data not shown), ruling out a low red blood cell
count as a mechanism for LV dysfunction.
Positional cloning of the Python mutation
The Python mutation was generated on a BALB/cAnN genetic
background, and the original mouse exhibiting the CHF
phenotype was a BALB/cAnNCrl x C3H/HeH F1 hybrid male.
This individual was backcrossed to C3H/HeH and offspring
exhibiting the CHF phenotype were examined with a panel of 53
polymorphic SNP markers spanning the entire genome at regular
intervals. A strong linkage signal was observed on chromosome 16
at marker D8Mit213 (LOD score of 3.3 for a recombination
fraction = 0.1). Subsequent fine mapping by backcrossing to C3H/
HeH, C3H/HeN and, finally, to C57BL/6J mice narrowed the
critical region containing the mutation to 787 Kb (Figure 2A).
Three genes are located within this region - Pkp2, Fdg4 and Dnm1l.
Sequencing of all exons and exon-intron boundaries identified
only a single mutation in Python mice; a G/C to T/A transversion
in exon 11 of the Dnm1l gene (the official gene name as specified by
the International Committee on Standardized Genetic Nomen-
clature for Mice but often referred to in the literature as Drp1 or
Dlp1) (Figure 2B). Based on the known ENU-induced mutation
rate for this strain and ENU dose (1 mutation per 1.8 Mb) [7], the
probability of there being an additional intronic or intergenic
mutation anywhere in this region is extremely low (P= 0.00001)
[8]. There was complete concordance between animals suffering
from CHF and the Python mutation. We retrospectively
regenotyped 145 DNA samples isolated from C3H and C57BL/
6J Python mice that had suffered from CHF and all contained the
mutation while it was absent in 189 samples from non-affected
littermate control mice. None of the wild types strain examined
(BALB/cAnNCrl, C3H/HeN, C3H/HeH, C57BL/6J, DBA/2J,
CBA/J, 101/H, 129/S5) contained the mutation. Although PKP2
dominant mutations have been associated with arrhythmogenic
right ventricular cardiomyopathy in humans [9] an intronic or
intergenic mutation is unlikely to account for the Python
Author Summary
Heart disease is very common. Some cases of heart disease
are strongly influenced by lifestyle and diet, whereas
others have a strong genetic component. A certain form of
heart failure, known as dilated cardiomyopathy (DCM)
quite often runs in families suggesting that a defective
gene or genes underlie this disease. We describe a new
mouse mutant called ‘‘Python’’ which suffers from a heart
disease similar to DCM. We were able to pinpoint the
defective gene responsible for the disease. This gene is
normally involved in the division of mitochondria, the
‘‘power plants’’ of the cell that generate one of the main
energy supplies for the cell. This is a unique model that
implicates a new gene and mechanism of disease for
further investigation.
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Figure 1. The Python mutation leads to dilated cardiomyopathy. (A) A 13-week-old Python mouse compared to a littermate control. (B)
Kaplan-Meier analysis of onset of overt CHF in Python mice on the C3H/HeN and C57BL/6J genetic backgrounds compared to wild type littermate
controls. (C) Photo of the excised hearts from a 13-week-old Python and wild type mouse. Note the grossly enlarged ventricles and atria. (D) H&E
section through a wild type and Python heart showing showing clinical signs of CHF. Note the distended ventricles; R = right, L = left. (E) Oedematous
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phenotype as all human PKP2 mutations found to date occur in
the coding region or splice sites which are not mutated in Python
mice, the homozygous phenotype for the null Pkp2 mutation is
very different from the Python homozygote [10] and Pkp2 mRNA
level is not altered in Python hearts as judged by microarray
analysis (data not shown) suggesting no disease-causing non-coding
regulatory changes. These facts, coupled with the observation that
ENU-induced mutations resulting in detectable phenotypes occur
almost exclusively in the coding exons or exon-intron boundaries
of genes [11], strongly suggested that this base change was the
Python mutation.
The Python mutation results in the replacement of the cysteine
by a phenylalanine at position 452 in the predicted Dnm1l protein
(amino acid numbering according to EBI reference protein
Accession No. Q8K1M6) (Figure 2C). This cysteine is located
within the middle (M) domain of the protein and is fully conserved
in all Dnm1l orthologues, and even the yeast dynamin homologue
DNM1 (Figure 2D). The degree of evolutionary conservation of
the Dnm1l protein is very high. For example, overall homology
between human and mouse Dnm1l is 98%, and between zebrafish
and mouse is 89%. The M domain conservation is even higher
with 96% sequence conservation between mouse and zebrafish
over the 291 amino acids of this domain. The cysteine residue is
also conserved in the M domain of the mouse homologues of
Dnm1, Dnm2 and Dnm3 (Figure 2E) despite overall homology
with these domains being less than 40% (Table S1) suggesting that
this cysteine plays an important role in M domain function.
The Python mutation impairs intramolecular interaction
of Dnm1l
There is no available crystal structure of any mammalian
dynamin proteins but a crystal structure has been described for a
bacterial dynamin-like protein. In this structure the M domain
forms an elongated alpha-helical domain where the tip of the M
domain helices interact with a similar region of the ‘mate’ in the
dynamin homodimer [12]. Accordingly, a model of mouse Dnm1l
was constructed on the basis of comparative sequence homology to
the bacterial dynamin-like protein BDLP for which there is a
crystal structure [12] and an electron cryomicroscopy reconstruc-
tion of BDLP assembled around a lipid tube [13]. A predicted
structure could be created for most of the protein, apart from one
region where there is no homology in BDLP (indicated by an ‘a’ in
Figure 3A). The predicted structure of the dimeric asymmetric
repeating unit in the extended confirmation (i.e. after lipid
binding) is shown in Figure 3A.
There are six mutations, all dominant or semi-dominant, that
have been reported in the M of domain of DNM1L or its yeast
homologue DNM1–three in yeast [14], and one each in a human
Table 1. Cardiovascular parameters in 11-week-old male mice.1
Littermate controls (n=6) Python (n=6) P value
Organ weights
Body weight (g) 34.062.8 32.562.1 0.31
LV weight (mg) 9466 9066 0.30
RV weight (mg) 2864 2763 0.72
Lung weight (mg) 13865 141616 0.65
Echocardiography
End-diastolic area (cm2) 0.12360.015 0.13260.009 0.22
End-systolic area (cm2) 0.06960.017 0.08260.014 0.19
Ejection fraction (%) 4468 3869 0.24
Wall thickness (mm) 0.8260.03 0.8060.03 0.19
Heart rate (bpm) 460652 461659 0.98
Haemodynamics
LV systolic pressure (mmHg) 9768 7563 0.00007
LV end-diastolic pressure (mmHg) 3.861.1 17.769.2 0.004
dP/dtmax(mmHg/s) 853161084 514061135 0.0004
dP/dtmax/instantaneous pressure (s
21) 14968 107623 0.002
dP/dtmin(mmHg/s) 2844961381 2456461308 0.001
Tau (ms) 8.561.5 16.666.8 0.017
Mean arterial pressure (mmHg) 7569 6066 0.006
Central venous pressure (mmHg) 1.862.0 1.660.8 0.83
Dobutamine dP/dtmax(mmHg/s) 1300361832 634461424 0.00004
1Mice were on a C3H/HeN genetic background. All data is mean 6 SD with comparisons made by Student’s t-test.
doi:10.1371/journal.pgen.1001000.t001
dermal connective tissue evident in a H&E-stained section from a Python mouse showing clinical signs of CHF compared to a littermate control. (F)
MSB staining of heart sections of Python mice showing clinical signs of CHF. Note enlarged cardiomyocytes (indicated by red bracket) and increased
collagen deposition (indicated by black bracket). (G) Morphometric analysis of MSB-stained section demonstrating the level of increase in collagen
deposition. Data shown is % of image area (mean 6 SEM) that is taken up by collagen deposition from 3 Py/+ showing overt signs of CHF and 3 +/+
age-matched males. Five images were taken per sample. (H) Evidence of cardiac calcification in a Von Kossa-stained section of a Python heart.
doi:10.1371/journal.pgen.1001000.g001
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patient [15], a CHO cell line [16], and Python (Figure S1). These
were mapped on to the predicted structure (Figure 3A). The
Python mutation is located in an alpha-helix that is not predicted
to affect interaction between Dnm1l monomers. However, it is
located close to several other helical regions of the domain M.
Furthermore, a helix-wheel projection of the region around the
Python mutation-containing region predicts that one face of the
predicted helix contains principally hydrophobic residues
(Figure 3B). Taken together, these findings are suggestive of this
face being involved in an intramolecular interaction within the
Dnm1l monomer.
To test this further, we used the yeast two-hybrid assay based on
GAL4 DNA binding and activation domain interactions to
examine whether interactions between regions of Dnm1l could
be altered by the Python mutation. We used regions of the protein
that have been used by others in similar assays [17–22] and
examined all possible reciprocal interactions of bait (in pDEST32)
and prey (in pDEST22) proteins for regions of Dnm1l: full-length,
N-terminal region, C-terminal region, M domain and GED
(GTPase Effector Domain) (Figure 3C). On the basis of ability to
grow on medium lacking histidine and b-galactosidase activity, the
only strong interactions we identified were interactions between
the full-length proteins, the N terminal and C-terminal regions of
the proteins as reported by Zhu et al. [20], and the N-terminal
region and the GED (Figure 3D). We found that while the Python
mutation had negligible influence on the ability of the full-length
proteins to interact (Figure 3D and 3E), it abrogated the ability of
the N-terminal region to interact with both the C-terminal region
and the GED alone (Figure 3D). Quantitative assays for b-
galactosidase activity confirmed the substantial effect the Python
mutation had on these interactions (Figure 3E).
The Dnm1lPy mutation results in the impairment of
mitochondrial and peroxisomal dynamics
Given that the Python mutation occurs in a highly conserved
domain of the Dnm1l protein and alters protein interaction in vitro,
its effect on in vivo functions associated with Dnm1l were
examined. Protein levels of Dnm1l were not altered in either
heart or brain (Figure 4A) suggesting that there is no haploinsuffi-
ciency (i.e. the Python protein is assumed to be present). Dnm1l
was distributed diffusely within the cell in both Python and wild
type cultured skin fibroblasts (Figure 4B) suggesting that
introduction of the Python protein did not drastically alter
trafficking of Dnm1l. As Dnm1l function is involved in
mitochondrial and peroxisomal dynamics, cultured neonatal skin
fibroblasts were examined for morphology of both these
organelles. Mitochondrial morphology was altered. Python
mitochondria were highly elongated compared to wild type
controls (Figure 4C), as were peroxisomes (Figure 4D). To
determine if mitochondrial volume was altered, we utilized a
novel assay where cells were loaded with a fluorescent mitochon-
drial marker and analyzed by flow cytometry. Intensity of
fluorescence should reflect mitochondrial volume in the cell. As
shown in Figure 4E, there was no difference in overall
mitochondrial volume between Python and wild type fibroblasts,
despite the significant changes in mitochondrial shape. This
indicates that the Python mutation affects the in vivo functional
activity of Dnm1l, thereby impairing mitochondrial fission.
Homozygosity for the Python mutation is embryonic
lethal; heterozygosity for Python modifies mitochondrial
structure
To discern the functional effects of the Python mutation, we
intercrossed heterozygotes to obtain homozygous animals. Geno-
typing of embryos demonstrated that no homozygous Python
embryos could be recovered from E12.5 onwards (Figure 5A).
Homozygous embryos appear to be normal up to approximately
E9.5. At E11.5, Py/Py embryos were severely retarded in growth
and exhibited a posterior truncation (Figure 5B). The homozygous
embryonic phenotype is very similar to that recently reported for
the Dnm1l-null mutation [23–24]. Embryos die at a similar stage
and their morphology is similar. Mouse Embryonic Fibroblasts
(MEFs) cultured from homozygous E9.5 embryos survived poorly
in culture. Few cells attached and there was no proliferation
(Figure 5C). Mitochondria of Py/+ MEFs were abnormal with
numerous long tubular mitochondria (Figure 5C), similar to Py/+
skin fibroblasts. In contrast, homozygous Python MEFs had
grossly abnormal mitochondria. Whereas a tubular mitochondrial
network evenly distributed throughout the cytoplasm character-
ized mitochondria in +/+ and Py/+ MEFs, some mitochondria of
Py/Py MEFs appeared to be spherical and aggregated (Figure 5C).
This could reflect Dnm1l dysfunction alone though it may reflect a
general dysfunction of these cells. As mentioned earlier, these cells
fail to proliferate. Over several weeks in culture they slowly die.
The nuclei staining with Hoechst 33342 demonstrated evidence of
chromatin condensation in homozygous Python cells (Figure 5C),
suggesting the cells could be dying by necrosis.
The Dnm1lPy mutation results in the impairment of
energy metabolism in the heart
The observation that Python fibroblasts exhibit abnormal
mitochondria coupled with the well-recognized role of DNM1L
in mitochondrial fission [25] and the critical role of mitochondria
in both the normal function and the death of cardiomyocytes [26],
led us to examine the mitochondrial and energetic phenotype of
Python heterozygous mice in greater detail. Aside from the
development of CHF, the Python mice did not exhibit any features
prominently recognized in mitochondrial cytopathies, such as
metabolic, neurological and skeletal muscle defects. They
exhibited a normal general behavioral and functional profile as
defined by the SHIRPA series of tests (Table S2) [27], which
would reveal any major neurological abnormalities. Grip strength
(a reflection of muscle strength) was normal, as was muscle
histology as assessed from H&E-stained sections (data not shown).
Plasma lactate levels, an indicator of general metabolic dysfunc-
tion, were not elevated in Python mice aged 5–9 weeks compared
to wild type littermate controls (Figure 6A).
Given that the Python phenotype at a gross pathological level
appeared to be restricted to the heart, we examined the
mitochondrial phenotype of Python cardiomyocytes. There was
Figure 2. Genetic linkage analysis and positional cloning of the Pymutation. (A) Genotypes of two informative recombinants exhibiting the
Python phenotype. The mutation was localized to a 787 Kb interval (indicated by the bracketed region). (B) Sequence of part of the 11th exon of the
Dnm1l gene reveals a G–T substitution in the Python allele. The reading frame of part of exon 11 is shown with the amino acid substitution that
results. (C) ClustalW2 alignment of part of domain M of vertebrate Dnm1l orthologues and the yeast Dnm1 homologue. Note that the cysteine
residue is conserved in all species examined. Amino acid colours represent similarity groupings. (D) Alignment of the entire domain M of the mouse
dynamins Dnm1l, Dnm1, Dnm2 and Dnm3. Identical or functionally very similar amino acids are shown grouped together by colour on the basis of
size, charge and hydropathy. The arrow indicates the position of the cysteine altered by the Python mutation.
doi:10.1371/journal.pgen.1001000.g002
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little evidence of morphological change in Python cardiomyocyte
mitochondria. For example, we examined the nuclear:mitochon-
drial DNA ratio in Python hearts as mtDNA is lost when DNM1L
is down-regulated and mitochondrial fission impaired [28],
However, there was no alteration in the nuclear:mitochondrial
DNA ratio in Python hearts at any stage before the development of
overt CHF and even at this stage only some Python hearts showed
an increased ratio (Figure 6B). This suggests that a major
derangement of nuclear:mitochondrial DNA ratios was not a
generalized effect of the Python mutation.
There was evidence of mitochondrial function changes in hearts
of Python mice suffering from overt CHF. Examination by
enzyme immunohistochemistry for succinate dehydrogenase
(SDH) and cytochrome c oxidase (Complex IV) activities revealed
a reduction for both enzymes in Python hearts (Figure 6C). In the
case of SDH there is evidence of diminished myocellular enzyme
activity as indicated by less-intense staining. However for Complex
IV, the enzyme immunohistochemistry suggests that in the failing
heart, the change in Complex IV enzyme levels may be due to the
substantial fibrosis that occurs late in the disease process rather
than a change in enzyme activity. In vitro measurement of Complex
IV activity and quantity showed that both were proportionately
reduced by similar amounts in ailing Python hearts (Figure 6D),
indicating that the enzyme remains fully active but is less abundant
at 12 weeks of age. This reduction in overall levels at this age most
likely reflects the considerable fibrosis and loss of cells that occurs
in late-stage Python hearts.
Defects in mitochondrial enzyme activity are recognized as a
general phenomenon in CHF [29] and, therefore, the differences
observed in failing Python hearts might be secondary to the
primary cause of heart failure. To determine if the Python
mutation was affecting mitochondrial function prior to major
changes in heart structure, we examined heart samples from
Python and wild type littermates at 10 weeks of age. This is before
there are any overt signs of CHF though the cardiovascular data
above (Table 1) indicates that heart function is abnormal at this
stage. Electron micrographs of heart samples were examined.
Morphometric analysis of the proportional area occupied by
mitochondria (a reflection of overall volume per cell) revealed no
difference between Python hearts and controls (Figure 6E). This in
agreement with the flow cytometry findings in Python skin
fibroblasts (Figure 4E). Nor were myofibre widths significantly
different between Python hearts and controls (data not shown).
There was no evidence of the membrane pinching reported in the
Dnm1l-null mouse fibroblasts [Ishihara2009], nor was there
evidence of large aggregates as has been reported for in vitro
cultured DNM1L mutants [30]. However, the average size of a
mitochondrion was slightly smaller in Python hearts than wild type
hearts (Figure 6E). Smaller cardiomyocyte mitochondria have
been previously reported in some cases of heart failure [31–33]. In
the case of Python, if mitochondrial volume is not altered but
mitochondrial tubules are extended in length, then a smaller cross-
sectional transverse area of mitochondria would be consistent with
this.
If Dnm1l affects mitochondrial dynamics, we predicted that the
end point of this would be impairment of respiratory chain
function. Examination of mitochondrial enzyme complex activities
normalized to citrate synthase activity in heart samples from 10-
week-old mice revealed no differences (Figure 6F and 6G). There
was a slight reduction in the overall level of mitochondrial citrate
synthase activity in Python hearts at this age but it was not
statistically significant (Student’s t test, P= 0.11) (Figure 6G) also
suggesting that the total mitochondrial volume in Python hearts
was not reduced. As the end-point of respiratory chain function is
ATP synthesis, and given that down-regulation of DNM1L results
in a reduced rate of ATP synthesis [28,34], myocardial ATP and
total adenine nucleotide (TAN) levels were measured using HPLC.
Python hearts exhibited a dramatic, approximately 50%, reduc-
tion in ATP and TAN levels (Figure 6H and 6I) compared to
hearts from littermate controls. In liver and brain at the same age,
ATP and TAN levels were similar in Python mice and controls
(Figure 6H and 6I), indicating that the defect in ATP generation
was not a general one. These results were confirmed by using
complementary quantitative bioluminescence assays (Figure S2).
A range of metabolites in the heart was examined using high-
resolution 1H NMR spectroscopy and Gas Chromatography Mass
Spectrometry (GC-MS)-based metabolomic approaches [35] on
Python and control mice. The metabolite changes identified are
summarized in Table 2. Significant reductions in Python hearts
were noted in mitochondrial metabolic intermediates or accessory
molecules e.g. succinate, malate, fumarate, pyruvate (all associated
with the citric acid cycle), creatine, glucose, AMP and adenosine.
Two notable increases were in the amino acids glycine and
proline. These account for approximately 50% of the amino acids
in collagen, possibly reflecting the fibrosis in Python hearts.
Discussion
We report the identification, through ENU mutagenesis, of a
novel genetic cause of cardiomyopathy. Our principal finding is
that a missense mutation in the middle domain of Dnm1l, whose
product is critically involved in mitochondrial fission, results in
DCM. The resulting defect in mitochondrial remodelling renders
the Python hearts progressively energy deficient potentially
contributing to the phenotype [36].
The fundamental importance of mitochondrial remodelling in
mammalian pathophysiology has been underlined by in utero
lethality and cerebellar degeneration in mice with homozygous
Figure 3. Effect of the Python mutation on the Dnm1l protein. (A) Ribbon representation of the homology model of the dimeric form of
Dnm1l protein in the extended conformation and embedded in a lipid membrane. The dimeric conformation model and coordinates of the lipid
membrane were generated by the superposition of the structural model of human Dnm1l onto the structure of bacterial dynamin-like protein Bdlp2
[13]. The positions of amino acid mutations reported in yeast Dnm1 and mammalian Dnm1l are shown as sphere representations in pink. A region
that could not be modelled because of lack of a homologous region in BDLP is labelled with ‘a’. Colours indicate protein domains: GTPase (red), M
domain (yellow) and GED (blue). (B) A helix wheel projection of the mutation-containing region of the Dnm1l protein. The hydropathy indices of the
amino acids have been divided into relatively hydrophilic (blue) and relatively hydrophobic (red). An arrow indicates the cysteine that is substituted in
the Py allele. Note how this face of the alpha-helix is relatively hydrophobic. (C) The locations within Dnm1l of the protein sequences used in the yeast
two-hybrid analysis. (D) Yeast two hybrid analysis of all combinations of protein sequences as either bait (GAL4 DNA binding domain in pDEST32) and
prey (GAL4 activation domain in pDEST22). Duplicate yeast colonies from each transfection grown on a –trp-leu plate (top), –trp-leu-his +100 mM AT
(middle, colonies exhibiting growth are boxed in red) and a filter lift from the –trp-leu plate assayed for b-galactosidase activity (bottom). (E) Level of
b-galactosidase in liquid cultures from interactors detected in (D) along with comparison to those with introduced Python mutation. Levels shown
are relative to average of full-length wild type interaction. Each assay is the mean 6 SEM of 6 independent measurements from 6 individual colonies
for each combination.
doi:10.1371/journal.pgen.1001000.g003
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Figure 4. Mitochondrial and peroxisomal morphology is altered by the Python mutation. (A) Western blot analysis of total heart and liver
protein extracts from 5-week-old male mice of the indicated genotypes demonstrating that Dnm1l protein levels are not altered. Western blots were
re-examined using an anti-Tim23 antibody, an inner mitochondrial membrane protein, which demonstrate that the level of this mitochondrial protein
is also not altered in Python mutants. After stripping, a-tubulin was detected to demonstrate loading levels of protein extracts. (B) Typical example of
immunocytochemistry in neonatal mouse skin fibroblasts using an anti-DRP1 antibody. There was no appreciable difference between Python
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mutations in Dnm1l itself, as well as Mfn1, Mfn2, or Opa1
[23,37,38]. Given the heart’s manifest dependency on mitochon-
dria [39] as evidenced by its frequent involvement in mitochon-
drial disorders [40], mitochondrial remodelling defects might be
expected to occur in some forms of myocardial disease. Recently it
has been reported that mitochondria are smaller in failing hearts
and DNM1L protein levels were increased in DCM heart samples
[33] but until now, there has been no direct evidence that genes
involved in regulating mitochondrial dynamics might be involved
in heart failure. Python is the first such example.
DNM1L is a member of the dynamin superfamily. In the higher
order spirals formed by dynamin, the basic repeating unit appears
to be a dimer [41]. The association between the GED and M
domains forms a ‘stalk’ conformation through which strong inter-
molecular interactions of the dimers occur [41]. Mutations in the
M domain have accordingly been shown to adversely affect self-
assembly into a higher order oligomeric structures that are critical
to Dnm1l function [22] and conformational changes within this
region are associated with the constriction of dynamin tubes that
facilitates fission [42]. It is not difficult to envisage how the
substitution of a bulky hydrophobic phenylalanine residue into a
helix-rich region of the M domain (Figure 3A) has the potential to
modify interactions necessary for Dnm1l’s effective function. As a
corollary, our yeast two hybrid analysis showed Python’s capacity
to abrogate Dnm1l’s N-terminal region interacting with the C-
terminal region (and GED), while leaving the interaction between
Dnm1l monomers unaffected. A similar effect was reported when
the S637D mutation was introduced into Dnm1l [43]. This effect
of the mutation on Dnm1l higher order structure is consistent with
a dominant-negative mode of action. Since there appears to be no
change in overall Dnm1l protein levels, we propose that the
Python monomer is readily incorporated into dimers with the wild
type protein but fails to function effectively within that dimer due
to defective intramolecular interactions. If this model is accurate,
only 1 in 4 Dnm1l dimers might be expected to be fully functional.
This study cannot exclude a systemic (i.e. non-cardiac) impact of
the C452F mutation, though from a clinical perspective, most
tissues and organ functions appeared to be grossly spared. The
liver was the one organ that did show evidence of extra-cardiac
involvement but this might reflect congestive cardiac hepatopathy
caused by heart disease. The predominant cardiac phenotype in
the Python heterozygotes contrasts with the marked skeletal
muscle and metabolic abnormalities in the infant with a dominant
mutation in DNM1L [15]. It is unclear why the Python mutation
manifests an overt phenotype only in heart. The reported human
mutation in domain M, a dominantly acting alanine to aspartic
acid mutation, appears to be much more severe than the Python
mutation appeared to have a widespread metabolic defect. This
may be related to the location of the amino acid within the
structure and/or the chemical nature of the amino acid
substitutions involved. An inter-species difference in DNM1l
functionality is possible but unlikely given the extremely high
degree of inter-species conservation. All 7 mutations identified in
the M domain that affect mitochondrial dynamics are conserved
not only in the M domain of DNM1L orthologues across multiple
species (Figure S1), but are also conserved across the M domain of
DNM1, DNM2, DNM3 and DNM1L (Figure 2E). The human
alanine to aspartate mutation occurs in a region of the protein that
might interact with the membrane (Figure 3A). When overall
compatibility of the amino acid replacements are compared the
Python amino acid replacement scores significantly higher in
compatibility with its original amino acid in terms of hydropho-
bicity, size and charge compatibility (15.8, 9.4, 18.17 for the
Python mutation compared to 12.8, 8.6 and 12.82 for the A400D
human DNM1L mutation) [44]. Given that there is no evidence
that this cysteine is involved in disulphide bonding in DNM1L,
and its effect in the yeast two-hybrid system on intramolecular but
not intermolecular Dnm1l interactions, its effect on Dnm1l
function may be relative mild, still enabling the formation of
dimers but with reduced functionality.
Although the gross impact of the heterozygous C452F Dnm1l
mutation on cardiac morphology was relatively subtle at ,70
days, the corresponding functional and, even more so, the
biochemical phenotypes were apparent. This was reflected in
uniform lethality shortly thereafter. The degree of ATP deficiency
in the Python hearts at this age is, to the best of our knowledge,
unprecedented. The apparent fall of ATP levels to 44% of wild
type levels in hearts from 10-week-old mice (15.1 vs. 6.6 nmol
ATP/mg/protein in +/+ and Py/+ hearts at 10 weeks of age
confirmed by two independent means) may have been exaggerated
by increased fibrosis, yet still seems beyond the range by which it is
thought that cardiac [ATP] is allowed to diminish (,25% to 30%)
even in CHF [39]. We used an exacting method involving HPLC
to measure these levels to ensure they were as accurate as possible.
However a major caveat to these observations, is that the degree of
difference in ATP levels observed herein will inevitably be
exaggerated by the technical limitations associated with measuring
ATP levels in tissue samples after excision from the body. The
resulting rapid depletion of ATP pools may have precluded
accurate measurements. However, a difference in ATP levels
between Python and control hearts (that is not found in liver and
brains) may indicate that the Python mutation does espouse an
aberrant and progressive impact on myocardial energetics.
One possible explanation for the Dnm1l-mediated cardiomy-
opathy is cardiac energy deficiency. It is recognized that CHF is
associated with, and in many cases exacerbated by, cardiac energy
deficiency [36,39,45,46]. Indeed, the commonality of CHF to
numerous primary mitochondrial diseases represents an excellent
source of evidence that primary energy deficiency can and does
cause CHF [36,47]. As reduction of Dnm1l function is known to
impair cellular energetics [28,34] and as this pattern of cellular
energetic impairment is profoundly and progressively manifested
in Python hearts even in advance of gross cardiac dysfunction,
cardiac energy deficiency may contribute to the phenotype of
Python hearts and may be the proximate cause.
Detailed questions remain regarding the impact of the C452F
substitution. Further biochemical and cellular studies are needed
to investigate the hypothesis that such M domain mutations alter
the intra/inter-molecular interactions and alter the homo-
oligomerisation properties of Dnm1l [48]. Such studies will have
to explain why in the context of the subtle reticular mitochondrial
changes in Python, there is a discrepancy between the lack of an
fibroblasts and wild type littermate controls. (C) Typical example of mitochondria (shown in red after staining with Mitotracker Orange) from cultured
Python neonatal skin fibroblasts compared to littermate controls. (D) Typical example of peroxisomes (shown in green after incubation with an anti-
catalase antibody and FITC-labelled secondary antibody) from cultured Python neonatal skin fibroblasts compared to littermate controls. The areas in
C and D bounded by white squares are magnified and shown in the middle frames. Nuclei are stained with Hoechst 33258. (E) Typical example of
FACS analysis of early passage skin fibroblasts from a Python neonate and littermate control after labelling with Mitotracker Orange. The histogram of
fluorescence for both cells types is similar.
doi:10.1371/journal.pgen.1001000.g004
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Figure 5. Homozygosity for the Py allele results in embryonic lethality. (A) Distribution of genotypes of embryos recovered from Py/+ x Py/+
intercrosses. Embryo numbers genotyped at each time point were: E8.5–26, E9.5–48, E10.5–20, E11.5–19, E12.5 20, E13.5–21, E15.5–10 and E19.5–14.
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overall decrease in mitochondrial volume or function and the
degree of ATP depletion. There are a number of other metabolic
and cellular processes that could be altered by the Python
mutation. Calcium cycling, for example, is altered in cells lacking
the mitochondrial fission protein Mitofusin 2, reflecting its role in
endoplasmic reticulum (ER)-mitochondria tethering [49]. Inhibi-
tion of Dnm1l alters ER structure [50], though we could find no
alteration in the morphological appearance of the ER in Python
fibroblasts (data not shown). Nevertheless, further investigation of
Ca2+ uptake into mitochondria and release from ER is warranted.
An energy defect not reflected in altered respiratory complex
enzyme activity might also result from other disturbances such as
uncoupling of electron transport and ATP production, perturba-
tion of supercomplexes [51], cell cycling [52] organelle quality
control through autophagy, or generation of reactive oxygen
species [28]. It is possible that Python has effects on Dnm1l
function, unrelated to mitochondrial dynamics.
The tissue specificity of the Python defect warrants further
investigation. This may reflect unique properties of cardiomyo-
cytes, their mitochondria, or a unique role for Dnm1l in
cardiomyocytes. For example, a role for DNM1L in the heart
has been inferred by Ong et al. who observed that mitochondrial
fission protects the heart against ischemia/reperfusion [53]. One
strategy to address this question would be to effect conditional
inactivation of Dnm1l in cardiomyocytes, in a similar manner to
mitochondrial fusion factor elimination in skeletal muscle [54]. In
conclusion, we report the first model of mitochondrial remodeling
to be associated with cardiomyopathy. It is likely that the C452F
substitution in the M domain of Dnm1l alters the balance of
mitochondrial fission and fusion. The impairments in mitochon-
drial remodeling and function result in a relatively tissue specific
disease as manifested by rapidly progressive cardiomyopathy. It is
plausible that mutations in Dnm1l that are similarly subtle and
hence do not represent a barrier to viability, will be identified and
prove to be of importance in human disease.
Materials And Methods
Mice
Mice were maintained in high health status facilities with access
to food and water ad libidum. All work was approved by the Animal
Ethical Review Committees of MRC Harwell, University of
Sheffield and University of Leeds, and the UK Home Office, and
conducted with the highest quality of animal care and in
accordance with the 3Rs.
ENU mutagenesis
Adult BALB/cAnNCrl mice aged 10 weeks were mutagenized
by intraperitoneal injection of two weekly doses of 100 mg/kg
ENU, mated with C3H/HeH and F1 offspring screened for
abnormalities. Python mice were further backcrossed to C3H/
HeN and C57BL/6J. All tissue samples used for metabolic and
cellular analysis were derived from a line generated by inbreeding
of an N1l backcross to C3H/HeN.
Genetic mapping
Genome-wide low-resolution mapping was performed using
DNA samples from 15 N2 C3H/HeH backcross animals that were
identified as carriers based on the development of congestive heart
failure. Genomic DNA samples isolated from tail biopsies of these
animals were screened by PCR amplification and gel electropho-
resis with 53 microsatellite markers spaced at regular intervals
across the genome. Samples were genotyped as either homozygous
C3H or heterozygous BALB/c-C3H for each marker. For finer
mapping, crosses of Python mice with both C3H and C57BL/6J
were used, and further microsatellite markers polymorphic
between either BALB/c and C3H or BALB/c and C57BL/6J
were used to identify Python mice that were recombinant in the
critical region. Single nucleotide polymorphisms (SNPs) were
genotyped by sequencing of PCR products amplified with primers
flanking the SNP site. Sequencing of candidate genes involved
designing primer pairs to amplify individual exons as well as
flanking splice donor/acceptor sequences. All exons and splice
sites in the critical region were sequenced using homozygous as
well as heterozygous Python DNA, ensuring that no base changes
were missed.
Measurement of blood lactate
A small drop of blood was obtained from the lateral tail vein
and processed using a Lactate Pro analyzer (HabDirect, Southam,
UK).
Histology and TEM
Tissues for light microscopy were emersion fixed in 10% neutral
buffered formalin and wax-embedded 3 mm sections were stained
with haematoxylin and eosin or Mauritius Scarlet Blue (MSB).
Mice were perfusion fixed for TEM. In situ staining for succinate
dehydrogenase and Complex IV activities were a previously
described [47,55,56].
In vivo cardiac phenotyping
Conscious ECG measurements were obtained in unrestrained
male Python mice and littermate controls (n = 6 of each) at 10
weeks of age using the non-invasive AnonyMOUSE ECG
screening tool (Mouse Specifics Inc). One week after, at 7562
days of age, the same mice were anaesthetised with isoflurane and
placed on a homeothermic blanket. Parasternal short- and long-
axis views were obtained under 1.25% isoflurane anaesthesia
using an Agilent Sonos 5500 with 15 MHz transducer. The LV
was cannulated via the right carotid artery with a 1.4F Mikro-tip
conductance cannula (SPR-839, Millar Instruments). The
superior vena cava was cannulated with a second 1.4F Millar
cannula (SPR-671) to measure central venous pressure. Mice
were allowed at least 15 minutes equilibration before baseline
aortic and ventricular pressure measurements were obtained.
Dobutamine was given by intraperitoneal injection (1.5 mg/g
body weight) and pressure measurements obtained under
maximal b-adrenergic stimulation. Mice were then killed by
cervical dislocation and organs washed in heparinised saline,
blotted and weighed. Two experiments were performed daily,
alternating between genotypes for morning and afternoon
experiments.
Enzymatic assays
All activities were determined at 30uC. Prior to analysis cells
were subjected to three cycles of freezing and thawing to lyse
(B) Comparison of day 11.5 embryos heterozygous and homozygous for the Py allele. Homozygous embryos are growth retarded and have a severe
posterior truncation. (C) Comparison of day 9.5 +/+, Py/+ and Py/Py embryos. Typical examples of individual fibroblasts obtained from culturing these
embryos and stained with MitoTracker Orange are shown above. Below, typical examples of E9.5 embryonic fibroblasts in culture three days after
embryo harvest. Note that the Py/Py cells have failed to proliferate and only a single cell is visible in this field.
doi:10.1371/journal.pgen.1001000.g005
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membranes. Enzyme activities were assessed were assessed using a
Uvikon 940 spectrophotometer (Kontron Instruments Ltd,
Watford, UK). Complex I activity was measured according to
the method of Ragan et al. [57]. Complex II-III activity was
measured according to the method of King [58]. Complex IV
activity was measured according to the method of Wharton and
Tzagoloff [59]. Citrate synthase (CS; EC 1.1.1.27) activity was
determined by the method of Shepherd and Garland [60].
Enzyme activities were expressed as a ratio to citrate synthase to
compensate for mitochondrial enrichment in cell samples [61].
Measurement of Complex IV activity and quantity in terminal
heart samples used a Complex IV Mouse Duplexing (Activity +
Quantity) Microplate Assay Kit (Mitosciences, Eugene, OR)
according to the manufacturer’s instructions.
NMR and mass spectroscopy
Tissues were extracted using a methanol: chloroform: water
extraction procedure to separate aqueous soluble metabolites from
lipids as previously described [62]. Briefly, ,100 mg tissue were
pulverised with dry ice. 600 ml methanol: chloroform (2:1) was
added and the samples were sonicated for 15 min. Water and
chloroform were added (200 ml of each). The resulting aqueous
and organic layers were separated from the protein pellet. The
organic layer was dried overnight in a fume hood whilst the
aqueous extracts were evaporated to dryness using an evacuated
centrifuge (Eppendorf, Hamburg, Germany).
NMR spectroscopy. The aqueous extracts were rehydrated
in 600 ml D2O, buffered in 0.24 M sodium phosphate (pH 7.0)
containing 1 mM (sodium-3-(tri-methylsilyl)-2, 2, 3, 3-
tetradeuteriopropionate (TSP) (Cambridge Isotope Laboratories
Inc., Andover, MA, USA). The samples were analysed using an
AVANCE II+ NMR spectrometer operating at 500.3 MHz for the
1H frequency (Bruker Gmbh, Germany) using a 5 mm ATMA
TXI probe. Spectra were collected using a solvent suppression
pulse sequence to saturate the residual 1H water proton signal
(noesypr1d pulse sequence; relaxation delay = 2 s, t1 = 3 ms,
mixing time = 150 ms, solvent presaturation applied during the
relaxation time and the mixing time). 128 transients were collected
into 16 K data points over a spectral width of 12 ppm at 27uC.
GC-MS. Aqueous samples were derivatised using the
procedure reported [63]. 150 ml of the D2O sample used for
1H
NMR spectroscopy was evaporated to dryness in an evacuated
centrifuge and 30 ml methoxyamine hydrochloride (20 mg ml21 in
pyridine) was added. The samples were vortex mixed for 1 minute,
and derivatised at room temperature for 17 hours. Samples were
then silylated with 30 ml of N-methyl-N-trimethylsilyltri-
fluoroacetamide (MSTFA) for 1 hour at room temperature. The
derivatised samples were diluted (1:10) with hexane prior to GC-
MS analysis. Organic phase metabolites were derivatised by acid
catalyzed esterification [64]. Lipids were dissolved in 0.25 ml of
chloroform/methanol (1:1 v/v). 0.10 ml BF3/methanol (Sigma-
Aldrich) was added and the vials were incubated at 80uC for 90
minutes. Once cool 0.3 ml H2O (mQ) and 0.6 ml hexane was
added and each vial vortex mixed for one minute. The aqueous
layer was discarded and the remaining organic layer was
evaporated to dryness before reconstitution in 200 ml hexane for
analysis. The derivatised aqueous samples were injected into a
Thermo Electron Trace GC Ultra equipped with a
30 m60.25 mm ID 5% phenyl polysilphenylene- siloxane
column with a chemically bonded 25 mm TR-5MS stationary
phase (Thermo Electron Corporation; Injector temper-
ature = 220uC, helium carrier gas flow rate = 1.2 ml min21). The
initial column temperature was 70uC; this was held for 2 min then
increased by 5uC min21 to 310uC and was held for 20 min. The
derivatised organic metabolites were injected onto a ZB-WAX
column (30 m60.25 mm ID60.25 mm df; 100% polyethylene
glycol). The initial column temperature was 60uC; this was held for
2 min then increased by 10uC min21 to 150uC and then by 4uC
min21 up to a temperature of 230uC where it was held for 7 min.
The column eluent was introduced into a DSQ quadrupole mass
spectrometer (Thermo Electron Corporation) (transfer line
temperature = 310uC for aqueous metabolites and 240uC for
lipid metabolites, ion source temperature = 250uC, electron
beam = 70 eV). The detector was turned on after a solvent delay
of 240 s and data was collected in full scan mode using 3 scans s21
across a mass range of 50–650 m/z.
Data Analysis. NMR spectra were processed using ACD
SpecManager 1D NMR processor (version 8, ACD, Toronto,
Canada). Spectra were Fourier transformed following
multiplication by a line broadening of 1 Hz, and referenced to
TSP at 0.0 ppm. Spectra were phased and baseline corrected
manually. Each spectrum was integrated using 0.04 ppm. integral
regions between 0.5–4.5, and 5.1–10.0 ppm. To account for any
difference in concentration between samples each spectral region
was normalised to a total integral value of 10000. GC-MS
chromatograms were analysed using Xcalibur, (v. 2.0, Thermo
Fisher Corp), integrating each peak individually. Peaks were
normalised so that the total sum of peaks was set to 10000.
Figure 6. Cardiomyocyte energy metabolism is altered in Python mice. (A) Plasma lactate levels (mean 6 SEM) in adult Python (n = 29) and
wild type (n = 33) mice aged between 5 and 9 weeks and in mice. Sexes have been pooled. (B) The relative mitochondrial:nuclear DNA levels in heart
samples from Python and control mice as assessed using Q-PCR. ‘Py/+ overt’ refers to heart samples taken from Python mice at the time of overt
symptoms of heart failure. All other mice were aged between 5 and 7 weeks at time of sampling. *P,0.05, 1-way Anova with Bonferroni’s Multiple
Comparison Post-Test. (C) Typical example of enzyme histochemical staining for succinate dehydrogenase (SDH) and Complex IV from hearts of
Python males suffering from overt CHF (aged 93 days) and an age-matched littermate control. Typical sections stained with Haematoxylin and Eosin
(H&E) and Martius/Scarlet Blue (MSB) to stain connective tissue are shown for comparison. Note the scarring and loss of myocytes in Python hearts.
(D) Comparison of Complex IV activity and quantity (mean 6 SEM) measured in extracts from hearts of Python mice showing overt signs of CHF and
wild type controls aged 91–103 days (n = 7 Python, n = 7 controls). (E) Representative transmission electron micrographs of Python and control hearts
from mice aged 9–10 weeks. Scale bar = 2 mm. The graphs on the right summarizes the morphometric measurements (mean6 SEM) of mitochondrial
area (reflecting volume per cell) and mitochondrial size in Python (4 mice; n = 75 micrographs) and wild type (4 mice; n = 55 micrographs) heart EM
images. **P,0.01. (F) Mitochondrial respiratory complex enzyme activities (mean 6 SEM measured in extracts of heart tissue from Python (n = 8) and
control mice (n = 8) aged 10 weeks and normalized to level of citrate synthase activity. All activities expressed as nmol/min/mg total protein except
complex IV which is expressed as k/min/mg. Complex I: NADH: Ubiquinone reductase, Complex II–III: Succinate: Cytochrome c reductase, Complex IV:
Cytochrome c oxidase. (G) Overall citrate synthase activity (mean 6 SEM nmol/min/mg total protein) in heart extracts from H (n= 8 Python and n=8
wild type, Student’s t test P=0.12). (H) ATP level (mean6 SEM) after normalization to total protein level in extracts of tissue from Python and control
mice at age 10 weeks. Student’s t test P values are: heart +/+ (n = 7) vs. Py/+ (n = 6): P=0.006; liver +/+ (n = 6) vs. Py/+ (n = 6): P=0.80; brain +/+ (n = 6)
vs. Py/+ (n = 5): P= 0.29. (I) Total adenine nucleotide pool (TAN) in extracts of tissue from Python and control mice at age 10 weeks. Values shown are
mean6 SEM nmol ATP + ADP + AMP normalized to mg protein. Student’s t test P values are: heart +/+ (n = 7) vs. Py/+ (n = 6): P= 0.008; liver +/+ (n = 6)
vs. Py/+ (n = 6): P= 0.97; brain +/+ (n = 6) vs. Py/+ (n = 5): P= 0.31.
doi:10.1371/journal.pgen.1001000.g006
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Deconvolution of overlapping peaks was achieved by generating
traces of selected ions. A 0.1 minute threshold window was used
for the deviation of peaks away from the predicted retention time
across the data set. Structures were assigned using both the NIST
database of mass spectra and analysis of standard compounds.
Datasets were imported into SIMCA-P 10.0 (Umetrics, Umea˚,
Sweden) for processing using PCA, PLS (Partial least squares, a
regression extension of PCA used to separate out a trend from
other variation in the data set) and PLS-DA (a regression extension
of PCA used for classification). Identification of major metabolic
perturbations within the pattern recognition models was achieved
by analysis of corresponding loadings plots. Additionally, R2 and
Q2 were used as measures for the robustness of a pattern
recognition model. R2 is the fraction of variance explained by a
component, and cross validation of R2 gives Q2 which reveals the
fraction of the total variation predicted by a component. Both
values are indicative of how good the overall model is. Typically a
robust model has R2.0.50 and Q2.0.40. Coefficient scores rank
the observations according to their contribution to the model. In
order to confirm which metabolites contributed significantly to
each model, each variable was assessed by a jack-knifing routine to
assess its contribution to a given component. Only variables
deemed to have a coefficient significantly different from zero were
included.
Quantification of mtDNA and 18S rRNA by Q-PCR
100,000 cells were resuspended in 100 ml extraction solution
(0.2 mg/ml proteinase K, 0.2% SDS and 5 mM EDTA in PBS)
and incubated at 50uC for 3 h. Total DNA was then precipitated
by addition of 10 ml of 3 M sodium acetate (pH 5.2), 110 ml
isopropanol and incubation for 20 minutes on ice before
centrifugation at 12,000 rpm at 4uC. The DNA-pellet was
washed once with cold 70% ethanol, air dried for 15 min and
resuspended in 100 ml TE buffer at 4uC overnight. Realtime
PCR amplification was performed on 10 ng of total DNA using a
iCycler (Bio Rad) and iQ SYBR Green Supermix (BioRad)
following the manufacturer’s instructions. A 211 bp fragment of
the mtDNA 12S RNA gene was amplified between nucleotide
1095 and nucleotide 1305 (Forward primer: 59 GCTCGCCA-
GAACACTACGAG 39, reverse primer: 59 CAGGGTTTGCT-
GAAGATGGCG 39). Elongation translation factor 1 gene
(EEF1A1) was used as an endogenous reference across all
experimental conditions (Forward primer: 59 GGATTGCCA-
CACGGCTCACATT 39, reverse primer: 59 GGTGGA-
TAGTCTGAGAAGCTCTC 39).
Yeast two-hybrid analysis
Regions of Dnm1l were amplified from a mouse IMAGE cDNA
clone plasmid and cloned into the vectors pDEST22 (prey) and
pDEST32 (bait) (Invitrogen Ltd., Paisley, UK) according to the
manufacturer’s instructions. The two hybrid tests were performed
in the yeast strain MaV203, which contains a HIS3 promoter
driving expression of HIS3 and a GAL1 promoter to drive
expression of LACZ as chromosomally integrated reporter genes.
Interactions were initially tested by plating on yeast dropout
medium agar without leucine, tryptophan and histidine and with
increasing amounts of 3-amino-1,2,4-triazole (10, 25, 50 and
100 mM). Interactions were then further tested using a semi-
quantitative b-glactosidase filter lift assay followed by a quantita-
tive b-galactosidase liquid culture assay according to the Pro-Quest
instruction manual (Invitrogen Ltd., Paisley, UK).
Isolation of embryonic fibroblasts
For skin fibroblasts, 2–4-day-old pups were humanely culled,
and a portion of the skin removed, washed in PBS and finely
minced using a razor blade. A small piece of tissue was retained for
genotyping purposes. Numerous small segments of tissue approx-
imately 1 mm3 were placed well spaced on 10 cm Petri dishes and
allowed to air dry for 10 minutes, DMEM containing Glutamax
and 10% FCS (Invitrogen Ltd., Paisley, UK) was then carefully
added to the dish so as to avoid dislodging the tissue pieces. Plates
were cultured for 7 days at 37uC, 5% CO2, then outgrowing cells
were harvested with trypsin and passaged in the same medium.
For embryonic fibroblasts, embryos were dissected from the uterus
and the yolk sacs were removed for use in genotyping the embryos.
The embryos were placed in 50 ml 0.05% trypsin and macerated
using a 20 ml disposable pipette tip. After incubation for 15
minutes at 37uC, the cells were counted and plated in one well of a
6-well plate in DMEM containing Glutamax and 10% FCS and
cultured at 37uC, 5% CO2.
Table 2. Changes in metabolite levels measured in hearts
from Python mice and littermate controls.1
1H NMR spectra Metabolite
Python:
wt ratio
P value
(t test)
Increased in Python Aspartate 2.11 4.261029
Glutamate 1.15 5.161024
Glycine 1.67 4.8610215
Proline 1.24 1.461028
Valine/leucine/isoleucine 1.69 6.3610210
Decreased in Python Choline 0.80 1.661024
Creatine 0.69 2.3610211
Lactate 0.80 2.661025
Succinate 0.58 3.261028
Taurine 0.92 1.161023
Gas chromatography-
mass spectrometry
Increased in Python Asparagine 1.62 2.361024
Glycine 1.57 1.361028
Proline 2.35 3.161025
Threonine 1.82 3.361026
Uric acid 1.65 4.461024
Decreased in Python a-glycerophosphoric acid 0.69 3.561027
Adenosine 0.37 7.061027
AMP 0.27 5.761027
Creatine 0.44 1.561025
Fumarate 0.55 5.961025
Glucose 0.42 1.1.61024
1H-Indole-2,3-dione 0.37 2.161026
9H-Purine-6-amine 0.66 5.061024
Malate 0.59 2.561026
Myo-inositol 0.66 1.161025
Pyruvate 0.47 3.861027
Ribose 0.40 1.461023
Succinate 0.54 5.961025
1Mice were on a C3H/HeN genetic background. Average of individual
measurements from each heart sample of mice aged 10–11 weeks (n = 10 Py/+;
n = 10 +/+).
doi:10.1371/journal.pgen.1001000.t002
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Labeling of mitochondria in fibroblasts
For microscopy, fibroblasts were cultured on glass coverslips in
50–200 nM Mitotracker Orange CM-H2TMRos in DMEM
containing Glutamax and 10% FCS for 45 minutes at 37uC.
Cells were washed in PBS, then fixed in 4% paraformaldehyde for
20 minutes at room temperature. Cover slips were mounted on
glass slides in a drop of ProLong Gold mounting medium
(Invitrogen Ltd., Paisley, UK) containing 10 mg/mL Hoechst
33258. For FACS analysis, cells were harvested by trypsinization,
washed with PBS, then fixed for 20 minutes at 4uC in 4%
paraformaldehyde. Cells were subsequently centrifuged and
resuspended in PBS.
Western blot analysis
Brain and heart samples from 5-week-old mice were snap frozen
in liquid nitrogen then homogenized in RIPA (50 mM Tris-HCl
pH 8, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate,
0.1% SDS) containing 16 protease inhibitor cocktail (P8340;
Sigma-Aldrich, Dorset, UK). Equal amounts of protein were
separated by Laemmli stacking/separating SDS PAGE and
blotted to Hybond-P (GE Healthcare, Little Chalfont, UK), then
individual proteins were detected using antibodies to Drp1 (Clone
8; BD Biosciences, Oxford, UK), Tim23 (Clone 32; BD
Biosciences, Oxford, UK), and a-tubulin (T6074; Sigma-Aldrich,
Dorset, UK). An anti-mouse HRP-conjugated antibody (7076;
Cell Signaling, NEB, Hitchin, UK), was used for detection in
combination with ECL Western Blotting Detection Reagents (GE
Healthcare, Little Chalfont, UK).
Immunocytochemistry
For peroxisome labeling, a primary rabbit anti-catalase IgG
(ab16731, Abcam) was used with a goat anti-rabbit FITC-
conjugated IgG (ab6717, Abcam). For examining Dnm1l
distribution in fibroblasts, an anti-Drp1 primary antibody (Clone
8; BD Biosciences, Oxford, UK) with a Daylight549-conjugated
anti-mouse Ig was used.
Fluorescent imaging
All images were taken on a Zeiss AxioCam MRc5 microscope
using Axiovision Release 4.7.2 software. For imaging mitochon-
dria with Mitotracker Orange and Dnm1l using a Daylight549-
labelled secondary antibody, a filter with excitation 530–585 nm,
emission 600–660 nm was used. For Imaging peroxisomes with a
FITC-labeled secondary antibody, a filter with an excitation of
450–490 nm, emission 510–560 nm was used. For FACS
analysis, cells were incubated in 200 nM Mitotracker Orange
CM-H2TMRos in DMEM containing Glutamax and 10% FCS
for 45 minutes at 37uC, harvested using trypsin, washed with PBS
and fixed by incubation in 4% paraformaldehyde for 20 minutes
at 4oC. Cells were washed in PBS and resuspended in PBS
containing 1% FCS and analyzed for fluorescence on a
CyAnADP O2 flow cytometer (Dako). The gate for Mitotracker
Orange-positive cells was set using control cells that were not
labelled.
ATP and total adenine nucleotide pool measurements
Hearts were excised, washed in heparinised normal saline,
blotted and weighed, before being snap frozen in liquid nitrogen
and stored at 280uC. Total adenine nucleotide (TAN) content
and myocardial adenosine triphosphate (ATP) were measured by
High Performance Liquid Chromatography (HPLC) as previously
described [65]. For the purpose of calculating activity per mg of
protein, the Lowry method was used.
Homology modelling
The structure of the human DNMlL protein (Uniprot [66]
accession number O00429) was predicted by homology modelling
as follows. The structure of the bacterial dynamin-like protein
BDLP [13] (PDB [67] identification code 2w6d) was used as
template. Given the low sequence identity (around 12%), the
alignment between target sequence and template was performed
using a profile-to-profile alignment method implemented in the
FFAS03 server [68] (http://ffas.ljcrf.edu). Profile-to-profile align-
ments are superior in terms of sensitivity and alignment quality
compared to traditional pair wise alignments (and in particular at
low sequence identity). The FFAS03 score for the alignment was
233.5 implying significant similarity (FFAS03 scores below 29.5
reported less than 3% false positive under benchmarking
conditions [68]). The alignment was manually inspected and the
structural model was derived using MODELLER [69] as
previously described [70]. Structure representations were prepared
using the molecular visualization program PyMOL (http://www.
pymol.org).
Software and databases
DNA sequence alignments for detecting mutations were
performed using DNASTAR (DNASTAR Inc. Madison, WI).
Protein alignments were performed using CLUSTALW2 and
ALIGN software available online from the European Bioinfor-
matics Institute (www.ebi.ac.uk). Prism software (GraphPad
Software, Inc., La Jolla, CA) was used throughout for statistical
analysis. Morphometric analysis used ImageJ [71]. For measure-
ment of mitochondrial area and size, contrast of micrographs was
enhanced by 0.5%. After setting the scale, the threshold was
altered such that only mitochondria were marked. The thre-
sholded image was then analyzed for area, and area fraction for
particles greater than 50 pixels. For measurement of area stained
in MSB sections, the image type was set to RGB stack and the
threshold set to detect areas positive for collagen. The thresholded
image was then analyzed for area above threshold.
Supporting Information
Figure S1 Alignment of domain M in multiple species and
mutations found in Dnm1l protein homologues that have an effect
on mitochondrial morphology. Identical or functionally very similar
amino acids are shown grouped together by colour on the basis of
size and hydrophobicity. Reported mutations that result in amino
acid substitutions are 1, G269R yeast [14]; 2, G385D yeast [14]; 3,
G398S yeast [14]; 4, G369D hamster CHO cell line [16]; 5, A400D
human [15]; 6, P444L yeast [14]; 7, C452F mouse (Python).
Found at: doi:10.1371/journal.pgen.1001000.s001 (9.96 MB TIF)
Figure S2 ATP measurements (mean plus/minus SD) in heart
and brain samples expressed as level relative to wild type mean,
measured using a quantitative bioluminescent method. Tissue
samples were minced and then digested for 45 minutes in 10 mM
Tris pH 8.0 and 100 mg/ml proteinase K at 55uC. Protein
concentrations were estimated using a Bio-Rad DC Protein Assay
kit according to the manufacturers instructions. Samples were then
normalized based on total protein. ATP was measured using an
ATP Luminescence Assay Kit (Invitrogen Corp.) according to the
manufacturers instructions.
Found at: doi:10.1371/journal.pgen.1001000.s002 (0.71 MB TIF)
Table S1 Degree of similarity of domain M of mouse dynamin
proteins.
Found at: doi:10.1371/journal.pgen.1001000.s003 (0.03 MB
DOC)
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Table S2 SHIRPA Assessment of Python mice.
Found at: doi:10.1371/journal.pgen.1001000.s004 (0.04 MB
DOC)
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